Unrecognized Tax Benefits of Vistagen Therapeutics, Inc. from 31 Mar 2015 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Vistagen Therapeutics, Inc. quarterly Unrecognized Tax Benefits in USD history and change rate from 31 Mar 2015 to 31 Mar 2025.
  • Vistagen Therapeutics, Inc. Unrecognized Tax Benefits for the quarter ending 31 Mar 2025 was $2,399,000, a 51% decline year-over-year.
Source SEC data
View on sec.gov
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Change (%)

Vistagen Therapeutics, Inc. Quarterly Unrecognized Tax Benefits (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $2,399,000 -$2,532,000 -51% 31 Mar 2025 10-K 17 Jun 2025 2025 FY
Q1 2024 $4,931,000 +$3,648,000 +284% 31 Mar 2024 10-K 17 Jun 2025 2025 FY
Q1 2023 $1,283,000 +$195,000 +18% 31 Mar 2023 10-K 17 Jun 2025 2025 FY
Q1 2022 $1,088,000 +$156,100 +17% 31 Mar 2022 10-K 11 Jun 2024 2024 FY
Q1 2021 $931,900 +$117,300 +14% 31 Mar 2021 10-K 28 Jun 2023 2023 FY
Q1 2020 $814,600 +$145,900 +22% 31 Mar 2020 10-K 23 Jun 2022 2022 FY
Q1 2019 $668,700 +$217,100 +48% 31 Mar 2019 10-K 29 Jun 2021 2021 FY
Q1 2018 $451,600 +$161,100 +55% 31 Mar 2018 10-K 29 Jun 2020 2020 FY
Q1 2017 $290,500 +$148,100 +104% 31 Mar 2017 10-K 25 Jun 2019 2019 FY
Q1 2016 $142,400 +$94,200 +195% 31 Mar 2016 10-K 26 Jun 2018 2018 FY
Q1 2015 $48,200 31 Mar 2015 10-K 29 Jun 2017 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.